Enfermedad carotidea en Latinoamérica

PETTY GW, BROWN RD JR., WHISNANT JP, SOCKS JD, O'FALLON WM, WIEBERS OD. Ischemic stroke subtypes: a population-based study of incidence and risk factor. Stroke. 1999; 30:2513-16.

JOHNSTON SC, O'MEARA ES, MANOLIO TA, LEFKOWITZ D, O'LEARY DH, GOLDSTEIN S, CARLSON MC, FRIED LP, LONGSTRETH WTJR. Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerebrovascular disease. Ann Intern Med. 2004;140:237-47.

TOUBOUL PJ, VICAUT E, LABREUCHE J, ACEVEDO M, TORRES V, RAMIREZ-MARTINEZ J, VINUEZA R, SILVA H, CHAMPAGNE B, HERNANDEZ-HERNANDEZ R, WILSON E, SCHARGRODSKY H, CARMELA STUDY INVESTIGATORS. Prevalence of the metabolic syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study. Cardiovasc Diabetol. 2009;26(8):52-61.

BERNAL-PACHECO O, ROMÁN GC. Environmental vascular risk factors: New perspectives for stroke prevention. Journal of the Neurological Sciences 2007;262:60-70.

FLÓREZ-CARDONA JA, FLORES-SILVA F, CHIQUETE E, IREYES-MELO I, CANTÚ-BRITO C. Prevalencia de enfermedad carotídea en un hospital de tercer nivel de atención en Distrito Federal, México. Acta Neurol Colom 2012;28:187-93.

MARCUS H. Revascularization of asymptomatic high-grade carotid stenosis is still indicated in some cases. Stroke. 2011;42:1152-3.

INGALL TJ. Revascularization od asymptomatic high-grade carotis stenosis is not indicated with comtemporary stroke prevention medical theraphy. Stroke. 2011;42:1154-55.

SELIM MH, MOLINA CA. Medical versus surgical treatmente of asymptomatic carotid sten osis. The ever-changing nature of evidence-based medicine. Stroke. 2011;42:1156-57.